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Abstract
Infected airway epithelial cells up-regulate the expression of chemokines, chiefly IL-8, and antimicrobial molecules including
b-defensins (BD). Acinetobacter baumannii is a cause of hospital-acquired pneumonia. We examined whether A. baumannii
induced the expressions of IL-8 and BD2 by airway epithelial cells and the receptors implicated in bacterial detection. A549
and human primary airway cells released IL-8 upon infection. A. baumannii-infected cells also increased the expression of
BD2 which killed A. baummannii strains. IL-8 induction was via NF-kB and mitogen-activated kinases p38 and p44/42-
dependent pathways. A. baumannii engaged Toll-like receptor (TLR) 2 and TLR4 pathways and A549 cells could use soluble
CD14 as TLRs co-receptor. A. baumannii lipopolysaccharide stimulated IL-8 release by A549 cells and sCD14 facilitated the
recognition of the lipopolysaccharide. Mass spectrometry analysis revealed that A. baumannii lipid A structure matches
those with endotoxic potential. These results demonstrate that airway epithelial cells produce mediators important for A.
baumannii clearance.
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Introduction
Acinetobacter baumannii has been implicated in a variety of
nosocomial infections being the pulmonary compartment the
predominant site of infection [1]. The crude mortality of A.
baumannii ventilator associated pneumonias is as high as 75% [2].
A. baumannii infections are extremely difficult to treat because of
the widespread resistance of these bacteria to the major groups of
antibiotics [1]. Despite the clinical relevance of A. baumannii there
is little information on the virulence factors expressed by this
pathogen [1].
Inflammatory response plays an essential role in lung defence
against pathogens. This response includes, among others, the
production of pro-inflammatory and chemoattractant cytokines
[3–8]. In turn, chemokines are required for the recruitment of
neutrophils into airways which is a common histological finding in
patients with pneumonia, independently of the infecting microor-
ganism [9]. Current evidence shows that IL-8 targets neutrophils
to sites of attack through its chemoattractant and activating
properties [10]. It has become evident that airway epithelial cells
play a pivotal role in lung defense by detecting pathogens which
leads to the expression of co-stimulatory molecules and the release
of cytokines and chemokines that influence airway inflammation
[11]. Airway epithelial cells also produce antimicrobial molecules
being b-defensin (BD) 2 one of the most studied defensin [12,13].
The expression of BD2 by airway epithelial cells is induced by
cytokines or by the presence of pathogens [14–17] and it has been
shown that BD2 levels increase several folds in lung during
pneumonia [18].
A wealth of evidence indicates that members of the Toll-like
receptor (TLR) family are key receptors signaling the presence of
pathogens to airway epithelial cells [11] being TLR2 and TLR4
the most extensively studied TLRs. While TLR4 seems to be
mainly involved in the detection of lipopolysaccharide (LPS),
TLR2 responds to a variety of products from gram positive
bacteria [19–21].
It has been recently demonstrated that the release of pro-
inflammatory mediators, chemokines and the recruitment of large
number of neutrophils are essential for the clearance of A.
baumannii within the lungs [22–24]. Furthermore, evidence shows
that TLR4-dependent signaling plays an important role in sensing
of A. baumannii in vivo because TLR4-deficient mice challenged
with A. baumannii displayed an impaired lung inflammatory
response [22]. Taken into account the important role of airway
epithelial cells in orchestrating lung immunity, we hypothesized
that airway epithelial cells would play a key role in sensing A.
baumannii infections thereby leading to production of mediators
necessary for the clearance of A. baumannii. In this study, we
provide insight into the signaling pathways and receptors involved
in sensing A. baumannii by human airway epithelial cells.
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Bacterial strains, growth conditions and reagents
Non clonally related A. baumannii clinical isolates 1514, 670,
1064 and 1327, all of them resistant to cefotaxime, ceftazidime,
imipenem, amoxicillin, amikacin, piperacillin-tazobactam, doxy-
cycline, and colistin sulphate, were from the collection of A.
baumannii strains at the ‘‘Virgen del Rocı ´o’’ University Hospital,
(Seville, Spain). A. baumannii strain ATCC 17978 was obtained
from the ATCC. Bacteria were grown in Luria-Bertani (LB) at
37uC.
Caffeic acid phenethyl ester (CAPE), an NF-kB inhibitor, and
SB203580, a p38 MAPK inhibitor, were purchased from Sigma
whereas U0126, a p44/42 MAPK inhibitor, and SP600125, a
JNK inhibitor, were purchased from Calbiochem. Purified
recombinant human sCD14 was purchased from R&D Systems.
Cell culture and infections
Monolayers of human lung carcinoma cells (A549, ATCC
CCL185) and primary human airway epithelial cells (NHBE,
Lonza) were grown as previously described [25]. 18 h before
infection A549 cells were serum starved. Prior to the experiment,
A549 and NHBE cells were washed twice with PBS. Overnight-
grown bacteria were subcultured and grown to exponential phase,
harvested by centrifugation (20006g, 20 min, 5uC) and resus-
pended in PBS. Infections were performed using a multiplicity of
infection of 100 bacteria per cell. Cell viability was assessed by
trypan blue dye exclusion and it was .95% even after 8 h post
infection or after treatments with either CAPE, SB203580, U0126
or SP600125 for the times or concentrations used in this study.
IL-8 stimulation assay
Epithelial monolayers were infected for different time points.
Supernatants were removed from the wells, cell debris removed by
centrifugation, and samples were frozen at –80uC. IL-8 in the
supernatants was determined by a commercial ELISA (Endogen)
with a sensitivity ,2 pg/ml. Experiments were run in duplicate
and repeated at least three times.
Immunoblotting
Proteins from lysed cells (15 mg) were separated by 10% SDS-
PAGE, electrotransferred to nitrocellulose membrane and blocked
with 4% skimmed milk in PBS. Immunostaining for IkBa was
performed with polyclonal rabbit anti- IkBa antibody (Santa Cruz
Biotecnology) whereas immunostainings to assess phosphorylation
of NF-kB p65, mitogen-activated protein kinases (MAPKs) p38,
p44/42 and JNK were performed with polyclonal rabbit anti-
phospho p65, anti-phospho-p38 antibody, anti-phospho-p44/42
and anti-phospho-JNK antibodies respectively (Cell Signaling).
Immunoreactive bands were visualized by incubation with swine
anti-rabbit immunoglobulins conjugated to horseradish peroxidase
(Dako P0217) using the SuperSignal West-dura system (Pierce).
Blots were reprobed with polyclonal antibody anti human tubulin
to control that equal amounts of proteins were loaded in each lane.
Nuclear cytoplasmic fractionation
Nuclear and cytosolic proteins were extracted from approxi-
mately 5610
6 cells as previously described [25]. Briefly, A549 cells
were washed with ice-cold PBS and suspended in hypotonic buffer
(10 mM HEPES, 10 mM KCl, 2 mM MgCl2, 1 mM DTT,
0.1 mM EDTA, 0.2 mM NaF, 0.2 mM Na3VO4,1 mg/ml
leupeptin, 0.4 mM PMSF). The cells were left on ice for 15 min
and cytosolic preparation was made by addition of Nonidet P-40
(final concentration of 0.1%) followed by centrifugation (6500
rpm, 3 min, 4uC). The supernatant was collected as the cytosolic
fraction. The remaining pellet was resuspended in extraction
buffer (50 mM HEPES, 50 mM KCl, 300 mM NaCl, 0.1 mM
EDTA, 1 mM DTT, 10% glycerol, 0.2 mM NaF, 0.2 mM
Na3VO4, 0.1 mM PMSF) and incubated on ice for 20 min. with
agitation. The nuclear proteins in the supernatant were recovered
after centrifugation (12 0006g, 20 min, 4uC) to remove nuclear
debris. Proteins present in extracts were quantified using the
Coomassie protein assay (Pierce) referenced against a bovine
serum albumin standard and stored in aliquots at –80uC. Extracts
were used for western blot analysis using anti-NF-kB p65
antibodies (Santa Cruz, SC372). The quality of the fractionation
was confirmed using tubulin as a cytoplasmic marker and lamin
A/C as a nuclear marker.
Transfections and luciferase assays
A549 cells were seeded into 24-well tissue culture plates to get a
40–60% confluence 24 h later. Cells were washed twice with PBS
before transfection. Transfection experiments were carried out in
500 ml of Opti-MEM Reduced-Serum Medium (Invitrogen) using
Lipofectamine
TM 2000 Transfection Reagent following manufac-
turer’s recommendations (Invitrogen).
For luciferase experiments, the PathDetectH NF-kB cis-Report-
ing plasmid (250 ng; Stratagene) or vector containing 59-flanking
region of human BD2 (1 mg; [26]) were co-transfected with the
pRL-TK Renilla Luciferase control reporter vector (20 ng;
Promega). For luciferase assays, cells were lysed with Passive Lysis
Buffer (Promega). Luciferase activity was assayed using the Dual
Luciferase Assay kit according to the manufacturer’s instructions
(Promega). Firefly luciferase values were normalized to Renilla
control values. Results were plotted as Relative luciferase activity
compared with activity measured in non stimulated control cells.
The luciferase assay was carried out in triplicate on at least three
independent occasions.
Antimicrobial peptide resistance assay
The assay was done as we have recently described [27]. Briefly,
bacteria were grown at 37uC in 5 ml LB, harvested (50006g,
15 min, 5uC) in the exponential phase of growth and washed three
times with PBS. A suspension containing approximately 10
5 cfu/
ml was prepared in 10 mM PBS (pH 6.5), 1% Tryptone Soya
Broth (TSB; Oxoid), 100 mM NaCl. Aliquots (5 ml) of this
suspension were mixed in Eppendorf tubes with various
concentrations of BD2. In all cases the final volume was 30 ml.
After 3 h incubation, the contents of the Eppendorf tubes were
1:10 diluted with PBS and 100 ml immediately plated on LB agar.
Colony counts were determined and results were expressed as
percentages of the colony count of bacteria not exposed to
antibacterial agents. The 50% inhibitory concentration of BD2
(IC50) was defined as the concentration producing a 50%
reduction in the colony counts compared with bacteria not
exposed to the antibacterial agent.
All experiments were done with duplicate samples on three
independent occasions.
Small interfering RNA (siRNA)
RNA-mediated interference for downregulating TLR4 and
TLR2 was done by the transfection of TLR4 siRNA (catalogue
#HSS110818) or TLR2 siRNA (catalogue #HSS110813) pur-
chased from Invitrogen. Stealth
TM RNAi Negative Control
Medium and Low GC were used as control interference RNA
for TLR2 and TLR4 respectively. 20 nM of siRNA per well was
used for transfection using Lipofectamine
TM 2000 Transfection
Reagent and following manufacturer’s recommendations (Invitro-
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described.
Real time quantitative PCR (RT-qPCR)
Quantification of mRNA levels was conducted by RT-qPCR.
RNA was purified using a Nucleospin RNAII kit (Macherey-
Nagel) exactly as recommended by the manufacturer. cDNA was
obtained by retrotranscription of 1.5–2 mg of total RNA using a
commercial RT
2 First Strand kit as recommended by the
manufacturer (SABioscience). The reaction included one step to
eliminate traces of genomic DNA. Real-time PCR (RT-PCR)
analyses were performed with a Smart Cycler real-time PCR
instrument (Cepheid, Sunnyvale, CA). To amplify human TLR2
and TLR4, 500 ng of cDNA were used as a template in a 25-ml
reaction containing 1 x Quantitect SYBR Green PCR mix
(Qiagen) and QuantiTect Primer Assays [Qiagen; catalog
numbers QT00236131 (TLR2) and QT00035238 (TLR4)]. As
internal control we amplified the human housekeeping GAPDH
using 50 ng of cDNA and the following intron spanning primers:
(sense, 59- GAAGGTGAAGGTCGGAGTC-39; antisense, 59-
GAAGATGGTGATGGGATTTC-39). For detection of TLR2
and TLR4, the thermocycling protocol was as follows: 95uC for
15 min for hot-start polymerase activation, followed by 45 cycles
of denaturation at 95uC for 30 sec, annealing at 60uC for TLRs or
54uC for GADPH for 30 sec; and extension at 72uC for 30 sec. The
SYBR Green dye was measured at 521 nm during the annealing
phase. The threshold cycle (Ct) value reflects the cycle number at
which the fluorescence generated within a reaction crosses a given
threshold. The Ct value assigned to each well thus reflects the
point during the reaction at which a sufficient number of
amplicons have been accumulated. The relative mRNA amount
in each sample was calculated based on its Ct in comparison with
the Ct of GAPDH. Specificity of the PCR products was
determined by melting curve analysis and amplification products
were resolved on a 1.5% agarose gel to confirm the correct size of
the amplicons (92, 102 and 226 bp for TLR2, TLR4 and GAPDH
respectively).
LPS purification
A. baumannii ATCC 17978 LPS was purified from 10 mg of
lyophilized bacterial cells using the Tri-Reagent extraction method
as previously described [28]. LPS was further purified by DNAsa,
RNAase and proteinase K treatments [29] before precipitation
with 0.375 M magnesium chloride in 95% ethanol. The pellet was
resuspended in water and lyophilized. This LPS did not activate
the NF-kB dependent luciferase reported gene in HEK293 cells
transiently transfected with human TLR2 (for a description of the
assay see [30]).
Method for lipid A extraction
A. baumannii ATCC 17978 lipid A was extracted using an
ammonium hydroxide/isobutyric acid method [31] and subjected
to negative ion matrix-assisted laser desorption ionization time-of-
flight (MALDI-TOF) mass spectrometry analysis. Briefly, lyoph-
ilized cells (10 mg) were resuspended in 400 ml isobutyric acid/1M
ammonium hydroxide (5:3, v/v) and incubated in a screw-cap test
tube at 100uC for 2 h, with occasional vortexing. Samples were
cooled in ice water and centrifuged (2,0006g for 15 min). The
supernatant was transferred to a new tube, diluted with an equal
volume of water, and lyophilized. The sample was washed twice
with 400 ml methanol and centrifuged (2,0006g for 15 min). The
insoluble lipid A was solubilized in 100–200 ml chloroform/
methanol/water (3:1.5:0.25, v/v/v). Analyses were performed on
a Bruker Autoflex II MALDI-TOF mass spectrometer (Bruker
Daltonics, Incorporated) in negative reflective mode with delayed
extraction. Each spectrum was an average of 300 shots. A peptide
calibration standard (Bruker Daltonics) was used to calibrate the
MALDI-TOF. The ion-accelerating voltage was set at 20 kV.
Dihydroxybenzoic acid (Sigma Chemical Co., St. Louis, MO) was
used as a matrix. A few microliters of lipid A suspension (1 mg/ml)
were desalted with a few grains of ion-exchange resin (Dowex
50W-X8; H
+) in an Eppendorf tube. A 1 ml aliquot of the
suspension (50–100 ml) was deposited on the target and covered
with the same amount of the matrix suspended at 10 mg/ml in a
0.1 M solution of citric acid.
Statistical methods
Results are expressed as mean 6 SD. Differences between
experimental groups were analyzed by non-parametric two sided
Mann Whitney U-test or one-way analysis of variance using
Kruskal-Wallis contrasts as appropriate (GraphPad Sotware Inc.).
A p value lower than 0.05 was considered significant.
Results
A. baumannii induced the expression of IL-8 and b-
defensin 2 by human airway epithelial cells
We assessed whether A. baumannii induces the expression of IL-8
by human airway epithelial cells. Time-course experiments
showed that there was a correlation between the duration of the
infection with A. baumannii strain ATCC 17978 and the levels of
IL-8 secreted by A549 (Figure 1A) and NHBE cells (Figure 1B).
The widespread number of A. baumannii strains resistant to
antibiotics led us to explore whether the increased expression of
IL-8 by infected cells is a general theme for A. baumannii. All the
strains tested induced the secretion of IL-8 by A549 cells and there
was a correlation between duration of the infection and the
secretion of IL-8 (Figure 1C). No significant differences were found
in the levels of IL-8 induced by the strains at any time point
(Figure 1C).
Airway epithelial cells up-regulate the expression of BD2 upon
infection [15–17]. We sought to determine whether A. baumannii
increases the expression of BD2 in A549 cells. Cells were
transiently transfected with a luciferase reporter construct
controlled by the promoter region of BD2. This plasmid has been
used previously to monitor the expression of BD2 in airway
epithelial cells [26]. BD2-dependent luciferase activity was induced
by all A. baumannii strains tested (Figure 2A). Survival assays shown
in Figure 2B demonstrated that A. baumannii strains were
susceptible to BD2 (final concentration of 3 mg/ml) and no
significant differences were found between strains. To further
confirm these findings, we performed dose-response experiments
which allowed us to determine the 50% inhibitory concentration
(IC50) of BD2 for these strains. IC50 of BD2 for strain ATCC
17978 was 1.5160.03 mg/ml, which was similar to those found for
strains 1514, 670, 1064 and 1327 (1.8560.05 mg/ml,
1.0160.04 mg/ml; 1.3460.03 mg/ml and 1.6560.06 mg/ml re-
spectively; p.0.05 for all comparisons).
Activation of NF-kB and MAPKs signalling pathways is
required for A. baumannii-induced IL-8 expression
Given that several studies show that NF-kB activation is
associated with IL-8 expression [10], we sought to determine
whether A. baumannii activates this transcriptional factor. A549
cells were transiently transfected with a NF-kB-dependent
luciferase reporter followed by infection and A. baumannii-induced
NF-kB activation was measured as relative luciferase activity. NF-
kB-dependent luciferase acitivity was induced upon infection with
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canonical pathway of NF-kB activation IkBa, present in the
cytosol complexed to NF-kB dimers preventing nuclear translo-
cation, becomes phosphorylated which leads to ubiquitination of
the protein and its subsequent degradation by the proteosome
thereby allowing nuclear translocation of NF-kB, process also
linked to phosphorylation of the p65 subunit [32]. Therefore we
analyzed the levels of IkBa in cytoplasmic extracts of infected cells
by immunoblot. IkBa degradation was apparent 30 min post
infection whereas 120 min post infection the IkBa levels were
similar to those of non infected cells (Figure 3B). Concomitantly, A.
baumannii induced the nuclear translocation of NF-kB and the
phosphorylation of the p65 subunit (Figure 3C). To determine the
contribution of NF-kB activation to A. baumannii-induced IL-8
expression, we asked whether CAPE, a chemical inhibitor used to
block NF-kB signaling pathway [33], alters A. baumannii-induced
IL-8 expression. As shown in Figure 3D, CAPE reduced A.
baumannnii-triggered IL-8 levels. Control experiments showed that
addition of dimethyl sulfoxide (DMSO) (the vehicle solution used
for CAPE) to Acinetobacter-infected cells did not affect IL-8 levels
(pg/ml in the absence of DMSO 433665; pg/ml in the presence
of DMSO 505695). CAPE-treated cells (15 mg/ml) expressed
levels of IL-8 (95685 pg/ml) similar to those of non-treated cells
(113650 pg/ml). Collectively, these data demonstrated that IkBa-
dependent activation of NF-kB is required for A. baumannii
induction of IL-8 expression in A549 cells.
MAPKs are important regulators of pro-inflammatory gene
expression including IL-8 [10]. We asked whether MAPKs are
involved in A. baumannii-induced IL-8 expression. MAPKs p38,
p44/42 and JNK activations occur through phosphorylation of
serine and threonine residues. Western blot analysis revealed that
A. baumannii induced activation of the three MAPKs (Figure 3E).
To explore whether the activation of MAPKs is involved in A.
baumannii-induced IL-8 expression, the infections were carried out
in the presence of chemical inhibitors for each MAPK. Figure 3F
shows that SB203580, a specific inhibitor of p38 MAPK, reduced
A. baumannii-induced IL-8 expression. The p44/42 inhibitor,
U0126, also reduced A. baumannii-dependent IL-8 expression but
Figure 1. Acinetobacter baumannii induces the secretion of IL-8 by airway epithelial cells. (A–B) ELISA of IL-8 released by A549 (panel A) or
NHBE (panel B) cells left untreated (CON) or infected for different time points with A. baumannii ATCC 17978 (n=3). *, P,0.05 (for the indicated
comparisons; one-way ANOVA). (C) ELISA of IL-8 released by A549 left untreated (CON) or infected for different time points with different A.
baumannii strains (n=3). *, P,0.05 (results are significantly different from the results for untreated cells; one-way ANOVA).
doi:10.1371/journal.pone.0010033.g001
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JNK inhibitor, did not alter A. baumannii-induced IL-8 expression
(Figure 3F). SB203580, U0126 and SP600125-treated cells
secreted similar amounts of IL-8 (120695; 95667 and
135687 pg/ml, respectively) than non-treated cells (130675 pg/
ml). Taken together, these findings indicate that activation of
MAPKs p38 and p44/42 is involved in A. baumannii-induced IL-8
expression in A549 cells.
A. baumannii-induced IL-8 expression is dependent on
TLR activation
In most cases, the infection-dependent activation of NF-kB and
MAPKs signaling pathways is due to the engagement of TLRs
[34,35]. Therefore it could be predicted that TLR-dependent
signaling would be important in the recognition of A. baumannii by
A549 cells. To assess whether TLRs are involved in A. baumannii-
induced IL-8 expression, siRNA was used to knock-down TLR2 or
TLR4 expression in A549 cells. As shown in Figure 4A, in TLR2
knock-down cells, A. baumannii induced significantly less IL-8 than
in control cells. A decreased in the levels of IL-8 was also observed
in A. baumannii-infected TLR4 knock-down cells in comparison to
control cells (Figure 4A). The efficiency of siRNA-mediated
downregulation of target gene mRNA levels was confirmed by
RT-qPCR (Figure 4B).
CD14 is a 55-kDa GPI-linked glycoprotein which also
participates in pathogen recognition and uses TLRs as co-
receptors in signal transduction [36]. We and others have
previously demonstrated that A549 cells do not express CD14
on their surface [25,37,38]. Host cells lacking CD14 on their
surface can compensate its absence with soluble CD14 (sCD14)
[39–41]. To test the effect of CD14 on the activation of A549 cells,
recombinant human sCD14 was added to the culture medium.
When infections were performed in the presence of sCD14, the
secretion of IL-8 peaked when 1 ng/ml sCD14 was used
(Figure 4C). Higher doses of sCD14 did not further increase A.
baumannii-induced IL-8 levels. In fact, IL-8 levels were similar
between Acinetobacter-infected cells with and without 100 ng/ml
sCD14 (one-way ANOVA; p.0.05). Control experiments showed
that sCD14 alone, even at the highest dose tested, did not induce
the secretion of IL-8 by A549 cells (data not shown). In order to
explore the role of TLRs in sCD14-mediated signal transduction,
TLR2 or TLR4 were knocked down by siRNA and infections
were done in the presence of sCD14 (1 ng/ml). Results shown in
Figure 4D demonstrate that sCD14 did not increase A. baumannii-
induced IL-8 secretion in either TLR2 or TLR4 knock-down cells.
In summary, these data indicate that the recognition of A.
baumannii by A549 cells involved TLR2 and TLR4 and that A549
cells could use sCD14 as TLR co-receptor to detect A. baumannii.
A. baumannii LPS induced the expression of IL-8 by
human airway epithelial cells
We aim to investigate the inflammatory potential of A. baumannii
LPS in airway epithelial cells in comparison to Escherichia. coli LPS.
Both LPSs induced the secretion of IL-8 by A549 cells being
0.01 mg/ml the amount of both LPSs which significantly
stimulated the secretion of IL-8 (one-way ANOVA; p,0.05)
(Figure 5). When stimulations were done in the presence of sCD14
(1 ng/ml), a significant increase in the levels of IL-8 was found for
both LPSs (one-way ANOVA; p,0.05). However, the effect was
more dramatic for A. baumannii LPS than for E. coli one.
A. baumannii lipid A analysis
Given that the LPS lipid A moiety is the part of molecule
responsible for its bioactivity, we characterized the lipid A moiety
of strain ATCC 17978 by MALDI-TOF mass spectrometry.
Previous studies determined unambiguously that lipid A disac-
charide backbone of Acinetobacter species is composed of two 2-
amino-2-deoxyglucose residues (GlcNI and GlcNII) linked by a b-
(1-6) glycosidic linkage and phosphorylated at positions 1 and 49
[42–44]. In another hand, the lipid A structure of A. radioresistens
has been recently studied by MALDI-TOF. This species contained
predominantly hepta-acylated lipid A containing two phosphates,
two 2-amino-2-deoxyglucose residues substituted with either four
12:0(3-OH) and three 12:0, or three 12:0(3-OH), three 12:0 and
one 14:0(3-OH) [43]. Taken into account that a wealth of
evidence indicates that lipid A architecture is conserved within a
Figure 2. Acinetobacter baumannii up-regulates the expression of human b-defensin 2 (BD2) and it is susceptible to this defensin. (A)
A549 cells were transfected with BD2 luciferase reporter gene and Renilla luciferase plasmid. Cells were infected with A. baummannii strains and BD2
promoter activation was measured 6 h post-infection. Activity is normalized by correction of Renilla expression and is presented relative to the cells
untreated. CON, non infected cells. Bars represent mean 6 SD (n=3) *, results are significantly different (P,0.05; one-tailed t test) from the results for
non infected cells (CON). (B) Survival of bacteria (percentage of cell colonies with respect to not exposed to agents) in presence of 3 mg/ml of BD2.
Error bars display standard deviation from the mean of three experiments, each one run in duplicate.
doi:10.1371/journal.pone.0010033.g002
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PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10033Figure 3. Activation of NF-kB and MAPKs is required for Acinetobacter baumannii-induced IL-8 expression. (A) Activation of a NF-kB
luciferase reporter plasmid in A549 cells left non treated (CON) or infected for 6 h with A. baumannii ATCC 17978. Activity is normalized by correction
of Renilla expression and is presented relative to the cells untreated (the data are means and SD.; n=3). (B) Immunoblot analysis of IkBa levels in
lysates of A549 cells left untreated (time 0) or infected for different time points with A. baumannii ATCC 17978. Data are representative of three
independent experiments. (C) Upper panels, immunoblots showing p65 levels in nuclear and cytoplasmic extracts of A549 cells infected with A.
baumannii ATCC 17978 for different time points. Asterisk denotes a protein recognized by the antibody which is only present in nuclear extracts and
also serves as a loading control. Blots of cytoplasmic extracts were reprobed with polyclonal antibody anti human tubulin to control that equal
amounts of proteins were loaded in each lane. Lower panels, immunoblots showing phospho-p65 and tubulin levels in lysates of A549 infected with
A. baumannii ATCC 17978 for different time points. IL-1b (20 ng/ml for 30 min) was used as a positive control for NF-kB activation. The results are
representative of three independent experiments. (D) ELISA of IL-8 released by A549 cells left untreated (CON, white bar) or infected for 4 h with A.
baumannii ATCC 17978 in the absence or presence of different concentrations of CAPE, an inhibitor of NF-kB, which was added 1 h before infecting
the cells (n=3). (E) Immunoblots showing phospho-p38 (P-p38), phospho p44/42 (P-p44/42), phospho JNK (P-JNK) The results are representative of
three independent experiments. (F) ELISA of IL-8 released by A549 cells left untreated (CON, white bar) or infected for 4 h with A. baumannii ATCC
17978 in the absence or presence of different concentrations of SB203580 (5 and 10 mM; p38 MAPK inhibitor), U0126 (1 and 10 mM; p44/42 MAPK
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structure similar to that from A. radioresistens, perhaps with minor
structural modifications related to the type of acylation. Analysis of
the negative ion mass spectrum of the intact lipid A fraction of
strain ATCC 17978 revealed a major ion peak m/z 1,910 with two
minor associated peaks m/z 1,894 (Dm/z 16) and m/z 1,882 (Dm/z
28) attributable to certain microheterogenicity of the sample.
Proposed structure corresponding to m/z 1,910 would correspond
to a hepta-acylated lipid A with two 2-amino-2-deoxyglucose
residues, two phosphates, three 12:0(3-OH), two 14:0(3-OH) and
two 12:0 (Fig. 6A and B). Dm/z 16 indicates a non-stoichiometric
substitution of one 14:0(3-OH) with one 14:0. m/z 1,882 (Dm/z 28)
may represent four 12:0(3-OH), two 12:0 and one 14:0(3-OH).
Molecular species at m/z 1,728 and 1,712, corresponding to a
hexa-acylated lipid A, differ from m/z 1,910 and m/z 1,894 species
by missing 12:0 respectively (Figure 6A and B). Ion peak m/z 1,530
inhibitor) or SP600125 (5 and 10 mM; JNK MAPK inhibitor) which were added 2 h before infecting the cells (n=3). *, P,0.05 (results are significantly
different from the results for untreated cells; one-way ANOVA). D, P,0.05 (results are significantly different from the results for infected cells in the
absence of inhibitor).
doi:10.1371/journal.pone.0010033.g003
Figure 4. Role of TLR2, TLR4 and sCD14 in Acinetobacter baumannii-induced IL-8 expression. (A) ELISA of IL-8 secreted by A549 cells
transfected with either control, TLR2, or TLR4 siRNAs, which were left untreated (white bars) or infected for 4 h with A. baumannii ATCC 17978 (data
are means and SD.; n=3). *, P,0.05 (one-way ANOVA). (B) siRNA efficiency was quantified by RT-qPCR in samples from the same experiment shown
in panel A. mRNA level was normalized to GADPH and then relative mRNA levels in cells transfected with control siRNA or specific siRNA were
compared. mRNA levels in cells transfected with control siRNA were set to 100% (the data are means and SD.; n=3). (C) ELISA of IL-8 secreted by A549
left untreated (CON, white bar) or infected with A. baumannii ATCC 17978 for 4 h in the absence or presence of different amounts of sCD14 (n=3).
*, P,0.05 (results are significantly different from the results for untreated cells; one-way ANOVA). D, P,0.05 (results are significantly different from the
results for infected cells in the absence of sCD14). (D) ELISA of IL-8 secreted by A549 cells transfected with either control, TLR2, or TLR4 siRNAs, which
were left untreated (white bars) or infected for 4 h with A. baumannii ATCC 17978 in the presence or absence of sCD14 (1 ng/ml) (data are means and
SD.; n=3). *, P,0.05 (one-way ANOVA).
doi:10.1371/journal.pone.0010033.g004
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molecular species m/z 1,348 may correspond to a tetra-acyl lipid A
containing two 2-amino-2-deoxyglucose residues, two phosphates,
two 12:0(3-OH) and two 14:0(3-OH) (Figure 6A and B). Analysis
of the negative ion mass spectrum of the intact lipid A fraction of
A. baumannii strains 1514, 670, 1064 and 1327 (Figure S1) revealed
that lipid As of the four strains contained the major ion peaks m/z
1,910 and m/z 1,728 found in lipid A fraction of strain ATCC
17978 whereas minor ion peaks m/z 1,530 and m/z 1,348 were
also present in lipid A from strains 1514, 670 and 1327 but absent
in strain 1064.
Altogether, these data indicate that the lipid A fraction of A.
baumannii strains, including multidrug resistant ones, would contain
two major species corresponding to a hepta-acylated lipid A with
two 2-amino-2-deoxyglucose residues, two phosphates, three
12:0(3-OH), two 14:0(3-OH) and two 12:0 (m/z 1,910) or a
hexa-acylated lipid A with two 2-amino-2-deoxyglucose residues,
two phosphates, three 12:0(3-OH), two 14:0(3-OH) and one 12:0
(m/z 1,728).
Discussion
In this work, we demonstrate that A. baumannii infection of
airway epithelial cells results in the secretion of IL-8 and up-
regulation of BD2 expression. Mechanistically, we demonstrate
that A. baumannii-triggered IL-8 depends on the activation of NF-
kB, and MAPKs p38 and p44/42. In addition, we show that A.
baumannii engages TLR2 and TLR4 to activate the expression of
IL-8 and that sCD14 contributes to the recognition of this
pathogen.
Neutrophil infiltration is a hallmark of the initial acute
inflammatory response. In humans, IL-8 has a prominent role in
the recruitment and activation of neutrophils [10]. Animal
experiments have revealed that the predominantly neutrophilic
inflammation in the airways of infected mice is essential for the
eradication of A. baumannii from the lungs [22–24]. Furthermore,
clinical studies have shown that A. baumannii is a common isolate in
neutropenic febrile patients [46]. Therefore, our data showing that
A. baumannii-stimulated airway epithelial cells secrete high levels of
IL-8 are consistent with the idea that an important function of
airway epithelial cells is to initiate the lung influx of neutrophils.
All A. baumannii strains tested in this study, including multidrug
resistant clinical isolates, induced similar levels of IL-8 thereby
suggesting that this feature could be a general theme of A.
baumannii. It is then tempting to speculate that treatments designed
to boost this cell response would help to clear A. baumannii
infections, even those caused by multidrug resistant strains. Giving
support to this idea, in a mouse model of pneumonia,
administration of MIP-2, a functional mouse homologue of IL-8,
significantly enhanced the clearance of A. baumannii from the lungs
[23,24].
BDs are known to play an important role in lung innate
immune response due to their potent activity against gram
negative and positive bacteria, fungi, and viruses. However, BDs
not only protect the lung against invading microbes, but they also
modulate the host immune response by providing an interface
between innate and adaptive immune response [47–50]. Because
inflammatory cytokines and pathogens induce the expression of
BD2 [14–17], it is accepted that this defensin plays an important
role in host defence as inducible component of the epithelial
barrier. In the present study, we have shown that A. baumannii
strains not only up-regulated the expression of BD2 but also they
were susceptible to it. Therefore, these results demonstrate the
capacity of airway epithelial cells to produce mediators necessary
for the clearance of A. baumannii.
Our results revealed that A. baumannii activates NF-kB and
MAPKs signaling pathways in airway epithelial cells. Our findings
add further evidence to the hypothesis that epithelial cells lining
mucosal surfaces orchestrate a defense response upon pathogen
challenge by activating NF-kB and MAPKs-dependent signaling
pathways [51]. Although p38 and p44/42 MAPKs were required
for A. baumannii-induced IL-8, the pathogen also activated JNK
MAPK hence suggesting that there are other host cell responses
activated in a JNK MAPK-dependent manner. Future studies will
aim to identify these responses.
Accumulating evidence exist showing that engagement of TLRs
triggers the activation of NF-kB and MAPKs and subsequently the
production of cytokines and chemokines [52]. Therefore, we
speculated that activation of airway epithelial cells by A. baumannii
could involve TLRs-dependent signaling pathways. Our results
showed that both TLR2 and TLR4 play an important role in the
production of IL-8 by A. baumannii infected A549 cells. These data
are in partial agreement with the results reported by Knapp and co-
workers [22] that indicate that only TLR4-dependent signaling
plays an important role in sensing of A. baumannii in vivo because
TLR4-deficient mice displayed an impaired lung inflammatory
response upon A. baumannii infection. In contrast, TLR2-deficient
mice displayed an increased inflammatory response associated with
accelerated elimination of the pathogen from the lung. It should be
noted that in vivo scenario is quite complex and the final outcome of
the infection is dependent on the concerted action of several cell
types such as epithelial cells, alveolar macrophages, neutrophils and
lymphocytes, all of them expressing TLR2, recruited and/or
activated upon infection whereas here we have just tested the
interplay between A. baumannii and airway epithelial cells. In
addition, the discrepancy between our data and those obtained in
vivo may be also attributable to differences between mice and
humans related to TLR2-dependent recognition of Acinetobacter and
the cross-talks between different signaling cascades.
To further characterize the receptors involved in the generation
of A. baumannii-mediated responses, we evaluated the role of CD14
which may act as co-receptor for bacterial recognition in epithelial
cells [36]. Our results showed that A549 cells could use sCD14 as
Figure 5. Acinetobacter baumannii and Escherichia coli LPSs-
induced IL-8 from airway epithelial cells. A549 cells were
challenged with medium alone (dashed line) or with 0.001–1 mg/ml
of each LPS preparation in the absence (black symbols) or presence
(white symbols) of sCD14 (1 ng/ml). Supernatant IL-8 levels were
measured at 18 h. Results are presented as means and SD.; (n=3). n, m
A. baumannii LPS; #,N E. coli LPS.
doi:10.1371/journal.pone.0010033.g005
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sCD14 is present in the airways, the molecule has been detected in
bronchoalveolar fluid of healthy subjects [53] and we have
demonstrated that epithelial cells may serve as one possible source
of sCD14 because airway epithelial cells primed with inflamma-
tory cytokines release sCD14 [54].
Our data demonstrated that A. baumannii LPS stimulates airway
epithelial cells to secrete IL-8 thereby suggesting that this LPS-
Figure 6. Analysis of Acinetobacter baumannii lipid A. (A) Negative ion MALDI-TOF mass spectra of lipid A isolated from Acinetobacter baumannii
ATCC 17978. (B) Proposed structures of the main molecular species present in Acinetobacter baumannii ATCC 17978 lipid A.
doi:10.1371/journal.pone.0010033.g006
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Supporting this, Knapp and colleagues [22] showed that intranasal
administrated A. baumannii LPS indeed triggers the recruitment of
neutrophils to the lungs. The ability of LPSs to evoke
inflammatory responses and the potency of them are directly
related to the structure of the molecule which in turn affects the
interaction with the LPS receptor complex. Our structural analysis
of the lipid A moieties of five A. baumannii strains by MALDI-TOF
mass spectrometry revealed that A. baumannii lipid A is a
bisphosphorylated diglucosamine to which are attached at least
six saturated fatty acyl chains with lengths of 12 or 14 carbons.
This structure matches with the so-called ‘‘canonical lipid A
structure’’ which is associated with the highest level of activation of
the human immune system [55]. This maybe the molecular
explanation underlying the unusually severe systemic inflamma-
tory reaction in response to A. baumanniii infection found in some
individuals [56,57].
It is worth commenting on the clinical implications of our
findings. The global emergence of A. baumannii strains resistant to
virtually all antibiotics makes it urgent to develop effective
therapeutics based on new targets. Our findings together with
those obtained in vivo [22–24] argue in favour of therapies based
on stimulation of TLR-dependent pathways in airway epithelial
cells thereby leading to chemokine secretion and the subsequent
recruitment of neutrophils. However, due to the high entodotoxic
potential of A. baumannii LPS care should be taken to induce an
overwhelming and detrimental inflammatory response.
Supporting Information
Figure S1 Negative ion MALDI-TOF mass spectra of lipid As
isolated from Acinetobacter baumannii strains 670, 1514, 1327
and 1064.
Found at: doi:10.1371/journal.pone.0010033.s001 (6.53 MB TIF)
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